Case Analysis: T. A. Krishnaswamy vs State of Madras
Case Details
Case name: T. A. Krishnaswamy vs State of Madras
Court: Supreme Court of India
Judges: A.K. Sarkar, J.R. Mudholkar, R.S. Bachawat
Date of decision: 10 December 1965
Citation / citations: 1966 AIR 1022, 1966 SCR (3) 31
Case number / petition number: Criminal Appeal No. 40 of 1964; Criminal Appeal No. 22 of 1961
Proceeding type: Criminal Appeal
Source court or forum: Madras High Court
Source Judgment: Read judgment
Factual and Procedural Background
The appellant, T. A. Krishnaswamy, operated a shop that manufactured a drug marketed under the name “OKSAL.” Each container bore a label stating that the preparation contained benzoic acid, salicylic acid, zinc oxide and boric acid in specified proportions. The State of Madras prosecuted the appellant under section 18(a)(ii) read with section 27 of the Drugs Act, 1940, alleging that the label was false because the actual composition differed from the statement on the label.
A Government Analyst examined a sample of the drug and prepared a report in triplicate on Form 13, as required by Rule 46 of the Drugs Act Rules. The report recorded the quantities of the four substances found and indicated that each was present in amounts deficient of the proportions claimed on the label: benzoic acid by 15.5 per cent, salicylic acid by 25 per cent, zinc oxide by 25 per cent and boric acid by 46.3 per cent. The report did not describe any “protocols of the tests applied” because the analyst performed only an analysis, not a test.
The magistrate accepted the analyst’s report as evidence, convicted the appellant for misbranding, and sentenced him to a fine of Rs 125 and, in default of payment, one month of rigorous imprisonment. The appellant appealed to the Sessions Judge, who set aside the conviction and acquitted him. The State appealed to the Madras High Court, which reversed the Sessions Judge’s order, restored the magistrate’s conviction and sentence, and ordered the appellant to pay the fine. The appellant then obtained special leave to appeal to the Supreme Court of India (Criminal Appeal No. 40 of 1964), contending that the analyst’s report was not in the prescribed form because it omitted the protocols of the tests and therefore should have been inadmissible.
Issues, Contentions and Controversy
The Court was called upon to determine whether the Government Analyst’s report, produced to establish that the drug OKSAL was misbranded, satisfied the form prescribed by Rule 46 and Form 13, and consequently whether such a report could be admitted as conclusive evidence under section 25(3) of the Drugs Act. The specific controversy centered on the interpretation of the requirement that the report contain “results of test or analysis with protocols of the tests applied.”
The appellant contended that the report was inadmissible because it failed to state any test protocols, arguing that the omission violated the mandatory form prescribed by Rule 46 and that, without the protocols, the report could not be considered a report in the prescribed form. The State contended that the report was admissible as conclusive evidence because it complied with the form: the rule required protocols only when a test, not an analysis, was performed, and the analyst had performed an analysis. The State further argued that the appellant had not adduced any evidence to the contrary, so the report was conclusive under section 25(3).
Statutory Framework and Legal Principles
Section 18(a)(ii) read with section 27 of the Drugs Act, 1940 defined the offence of misbranding when a label contained false statements as to a drug’s composition.
Section 25(3) of the Drugs Act, 1940 provided that the report of the public analyst was evidence of the facts stated therein and that such evidence was conclusive unless the accused adduced evidence to the contrary in the manner laid down in the statute.
Rule 46 made under the Drugs Act required the Government Analyst, after completing a test or analysis, to forward a report in triplicate on Form 13 together with “full protocols of the tests applied.”
Form 13 (Head 7) prescribed the format for the analyst’s report, stating “Results of test or analysis with protocols of tests applied.” The legal question was whether the phrase “protocols of tests applied” was mandatory for a report of an analysis.
Court’s Reasoning and Application of Law
The Court first examined the language of Rule 46 and Form 13. It observed that the provisions distinguished between a “test” and an “analysis” and that the requirement to state protocols was attached to the performance of a test. Because the Government Analyst had performed only an analysis to determine the quantitative composition of the drug, the Court held that the rule did not compel the inclusion of test protocols in the report.
Having concluded that the report satisfied the statutory form, the Court then applied section 25(3). The report was therefore admissible as evidence, and, in the absence of any contrary evidence adduced by the appellant, the report was conclusive of the facts it stated. The Court noted that the appellant had offered no evidence to rebut the analyst’s findings, and consequently the statutory conclusive‑evidence rule operated in favour of the State.
The Court distinguished the earlier decision in Rai Kishan v. State of Uttar Pradesh, holding that that precedent concerned a report of a test and could not be extended to a report of an analysis. Accordingly, the Court rejected the appellant’s contention that the omission of protocols rendered the report non‑prescriptive and inadmissible.
Final Relief and Conclusion
The Supreme Court dismissed the appeal filed by special leave. No relief was granted to the appellant; the conviction and sentence originally imposed by the magistrate were upheld, and the order of the Madras High Court restoring the conviction remained in force. The Court affirmed that the Government Analyst’s report was in the prescribed form and admissible as conclusive evidence under section 25(3) of the Drugs Act, thereby upholding the conviction for misbranding.